{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:43:13Z","timestamp":1740120193447,"version":"3.37.3"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004079","name":"Konrad-Adenauer-Stiftung","doi-asserted-by":"publisher","award":["fellowship"],"award-info":[{"award-number":["fellowship"]}],"id":[{"id":"10.13039\/501100004079","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s11307-019-01350-5","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T05:58:37Z","timestamp":1554357517000},"page":"1182-1191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of rs12917 MGMT Polymorphism on [18F]FDG-PET Response in Pediatric Hodgkin Lymphoma (PHL)"],"prefix":"10.1007","volume":"21","author":[{"given":"Stefanie","family":"Kewitz-Hempel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Kurch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Cepelova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Volkmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Sauerbrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Knirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"P\u00f6pperl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Steinbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambros J.","family":"Beer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christof M.","family":"Kramm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten-Oliver","family":"Sahlmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Erdlenbruch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolf-Dieter","family":"Reinbold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Odparlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama","family":"Sabri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regine","family":"Kluge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3765-7068","authenticated-orcid":false,"given":"Martin S.","family":"Staege","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,3]]},"reference":[{"key":"1350_CR1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1055\/s-2004-822627","volume":"216","author":"D K\u00f6rholz","year":"2004","unstructured":"K\u00f6rholz D, Claviez A, Hasenclever D, Kluge R, Hirsch W, Kamprad F, D\u00f6rffel W, Wickmann L, Papsdorf K, Dieckmann K, Kahn T, Mauz-K\u00f6rholz C, Dannenberg C, P\u00f6tter R, Brosteanu O, Schellong G, Sabri O (2004) The concept of the GPOH-HD 2003 therapy study for pediatric Hodgkin\u2019s disease: evolution in the tradition of the DAL\/GPOH studies. Klin Padiatr 216:150\u2013156","journal-title":"Klin Padiatr"},{"key":"1350_CR2","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1200\/JCO.2009.26.9381","volume":"28","author":"C Mauz-K\u00f6rholz","year":"2010","unstructured":"Mauz-K\u00f6rholz C, Hasenclever D, D\u00f6rffel W, Ruschke K, Pelz T, Voigt A, Stiefel M, Winkler M, Vilser C, Dieckmann K, Karl\u00e9n J, Bergstr\u00e4sser E, Foss\u00e5 A, Mann G, Hummel M, Klapper W, Stein H, Vordermark D, Kluge R, K\u00f6rholz D (2010) Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin\u2019s lymphoma: the GPOH-HD-2002 study. J Clin Oncol 28:3680\u20133686","journal-title":"J Clin Oncol"},{"key":"1350_CR3","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s00259-014-2715-9","volume":"41","author":"D Hasenclever","year":"2014","unstructured":"Hasenclever D, Kurch L, Mauz-K\u00f6rholz C, Elsner A, Georgi T, Wallace H, Landman-Parker J, Moryl-Bujakowska A, Cepelov\u00e1 M, Karl\u00e9n J, \u00c1lvarez Fern\u00e1ndez-Teijeiro A, Attarbaschi A, Foss\u00e5 A, Pears J, Hraskova A, Bergstr\u00e4sser E, Beishuizen A, Uyttebroeck A, Schomerus E, Sabri O, K\u00f6rholz D, Kluge R (2014) qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma. Eur J Nucl Med Mol Imaging 41:1301\u20131308","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1350_CR4","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1200\/JCO.2014.59.4853","volume":"33","author":"C Mauz-K\u00f6rholz","year":"2015","unstructured":"Mauz-K\u00f6rholz C, Metzger ML, Kelly KM, Schwartz CL, Castellanos ME, Dieckmann K, Kluge R, K\u00f6rholz D (2015) Pediatric Hodgkin lymphoma. J Clin Oncol 33:2975\u20132985","journal-title":"J Clin Oncol"},{"key":"1350_CR5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature09754","volume":"471","author":"C Steidl","year":"2011","unstructured":"Steidl C, Shah SP, Woolcock BW, Rui L, Kawahara M, Farinha P, Johnson NA, Zhao Y, Telenius A, Neriah SB, McPherson A, Meissner B, Okoye UC, Diepstra A, van den Berg A, Sun M, Leung G, Jones SJ, Connors JM, Huntsman DG, Savage KJ, Rimsza LM, Horsman DE, Staudt LM, Steidl U, Marra MA, Gascoyne RD (2011) MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature 471:377\u2013381","journal-title":"Nature"},{"key":"1350_CR6","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1200\/JCO.2012.43.4589","volume":"31","author":"DW Scott","year":"2013","unstructured":"Scott DW, Chan FC, Hong F, Rogic S, Tan KL, Meissner B, Ben-Neriah S, Boyle M, Kridel R, Telenius A, Woolcock BW, Farinha P, Fisher RI, Rimsza LM, Bartlett NL, Cheson BD, Shepherd LE, Advani RH, Connors JM, Kahl BS, Gordon LI, Horning SJ, Steidl C, Gascoyne RD (2013) Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma. J Clin Oncol 31:692\u2013700","journal-title":"J Clin Oncol"},{"key":"1350_CR7","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","volume":"352","author":"ME Hegi","year":"2005","unstructured":"Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JEC, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997\u20131003","journal-title":"N Engl J Med"},{"key":"1350_CR8","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1093\/nar\/20.12.2933","volume":"20","author":"P Karran","year":"1992","unstructured":"Karran P, Bignami M (1992) Self-destruction and tolerance in resistance of mammalian cells to alkylation damage. Nucleic Acids Res 20:2933\u20132940","journal-title":"Nucleic Acids Res"},{"key":"1350_CR9","first-page":"793","volume":"59","author":"M Esteller","year":"1999","unstructured":"Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG (1999) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 59:793\u2013797","journal-title":"Cancer Res"},{"key":"1350_CR10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/em.2850220418","volume":"22","author":"B Kaina","year":"1993","unstructured":"Kaina B, Fritz G, Coquerelle T (1993) Contribution of O6-alkylguanine and N-alkylpurines to the formation of sister chromatid exchanges, chromosomal aberrations, and gene mutations: new insights gained from studies of genetically engineered mammalian cell lines. Environ Mol Mutagen 22:283\u2013292","journal-title":"Environ Mol Mutagen"},{"key":"1350_CR11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1158\/1078-0432.CCR-05-2543","volume":"12","author":"L Liu","year":"2006","unstructured":"Liu L, Gerson SL (2006) Targeted modulation of MGMT: clinical implications. Clin Cancer Res 12:328\u2013331","journal-title":"Clin Cancer Res"},{"key":"1350_CR12","first-page":"6423","volume":"52","author":"TC Ayi","year":"1992","unstructured":"Ayi TC, Loh KC, Ali RB, Li BF (1992) Intracellular localization of human DNA repair enzyme methylguanine-DNA methyltransferase by antibodies and its importance. Cancer Res 52:6423\u20136430","journal-title":"Cancer Res"},{"key":"1350_CR13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.leukres.2013.11.001","volume":"38","author":"S Kewitz","year":"2014","unstructured":"Kewitz S, Stiefel M, Kramm CM, Staege MS (2014) Impact of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and MGMT expression on dacarbazine resistance of Hodgkin\u2019s lymphoma cells. Leuk Res 38:138\u2013143","journal-title":"Leuk Res"},{"key":"1350_CR14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.canlet.2005.01.038","volume":"231","author":"VF Chekhun","year":"2006","unstructured":"Chekhun VF, Kulik GI, Yurchenko OV, Tryndyak VP, Todor IN, Luniv LS, Tregubova NA, Pryzimirska TV, Montgomery B, Rusetskaya NV, Pogribny IP (2006) Role of DNA hypomethylation in the development of the resistance to doxorubicin in human MCF-7 breast adenocarcinoma cells. Cancer Lett 231:87\u201393","journal-title":"Cancer Lett"},{"key":"1350_CR15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0145-2126(86)90084-6","volume":"10","author":"HG Drexler","year":"1986","unstructured":"Drexler HG, Gaedicke G, Lok MS, Diehl V, Minowada J (1986) Hodgkin\u2019s disease derived cell lines HDLM-2 and L-428: comparison of morphology, immunological and isoenzyme profiles. Leuk Res 10:487\u2013500","journal-title":"Leuk Res"},{"key":"1350_CR16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1182\/blood.V68.1.285.285","volume":"68","author":"H Kamesaki","year":"1986","unstructured":"Kamesaki H, Fukuhara S, Tatsumi E et al (1986) Cytochemical, immunologic, chromosomal, and molecular genetic analysis of a novel cell line derived from Hodgkin\u2019s disease. Blood 68:285\u2013292","journal-title":"Blood"},{"key":"1350_CR17","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1182\/blood.V87.8.3418.bloodjournal8783418","volume":"87","author":"J Wolf","year":"1996","unstructured":"Wolf J, Kapp U, Bohlen H, Kornacker M, Schoch C, Stahl B, M\u00fccke S, von Kalle C, Fonatsch C, Schaefer HE, Hansmann ML, Diehl V (1996) Peripheral blood mononuclear cells of a patient with advanced Hodgkin\u2019s lymphoma give rise to permanently growing Hodgkin-reed Sternberg cells. Blood 87:3418\u20133428","journal-title":"Blood"},{"key":"1350_CR18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF01007965","volume":"38","author":"M Schaadt","year":"1979","unstructured":"Schaadt M, Fonatsch C, Kirchner H, Diehl V (1979) Establishment of a malignant, Epstein-Barr-virus (EBV)-negative cell-line from the pleura effusion of a patient with Hodgkin\u2019s disease. Blut 38:185\u2013190","journal-title":"Blut"},{"key":"1350_CR19","first-page":"615","volume":"66","author":"V Diehl","year":"1982","unstructured":"Diehl V, Kirchner HH, Burrichter H, Stein H, Fonatsch C, Gerdes J, Schaadt M, Heit W, Uchanska-Ziegler B, Ziegler A, Heintz F, Sueno K (1982) Characteristics of Hodgkin\u2019s disease-derived cell lines. Cancer Treat Rep 66:615\u2013632","journal-title":"Cancer Treat Rep"},{"key":"1350_CR20","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.2174\/1871520616666160219131657","volume":"16","author":"CD K\u00fchn\u00f6l","year":"2016","unstructured":"K\u00fchn\u00f6l CD, Staege MS, Kramm CM (2016) Lenalidomide in an in vitro Dendritic Cell Model for Malignant Gliomas. Anti Cancer Agents Med Chem 16:1468\u20131473","journal-title":"Anti Cancer Agents Med Chem"},{"key":"1350_CR21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0031-1287834","volume":"223","author":"R Kluge","year":"2011","unstructured":"Kluge R, K\u00f6rholz D (2011) Role of FDG-PET in staging and therapy of children with Hodgkin lymphoma. Klin Padiatr 223:315\u2013319","journal-title":"Klin Padiatr"},{"key":"1350_CR22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1055\/s-0033-1354416","volume":"225","author":"L Kurch","year":"2013","unstructured":"Kurch L, Mauz-K\u00f6rholz C, Bertling S, Wallinder M, Kaminska M, Marwede D, Tchavdarova L, Georgi TW, Elsner A, Barthel A, Stoevesandt D, Hasenclever D, Sattler B, Sabri O, K\u00f6rholz D, Kluge R (2013) The EuroNet paediatric hodgkin network - modern imaging data management for real time central review in multicentre trials. Klin Padiatr 225:357\u2013361","journal-title":"Klin Padiatr"},{"key":"1350_CR23","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00259-008-0826-x","volume":"35","author":"J Stauss","year":"2008","unstructured":"Stauss J, Franzius C, Pfluger T, Juergens KU, Biassoni L, Begent J, Kluge R, Amthauer H, Voelker T, H\u00f8jgaard L, Barrington S, Hain S, Lynch T, Hahn K, European Association of Nuclear Medicine (2008) Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology. Eur J Nucl Med Mol Imaging 35:1581\u20131588","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1350_CR24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1200\/JCO.2006.08.2305","volume":"25","author":"ME Juweid","year":"2007","unstructured":"Juweid ME, Stroobants S, Hoekstra OS, Mottaghy FM, Dietlein M, Guermazi A, Wiseman GA, Kostakoglu L, Scheidhauer K, Buck A, Naumann R, Spaepen K, Hicks RJ, Weber WA, Reske SN, Schwaiger M, Schwartz LH, Zijlstra JM, Siegel BA, Cheson BD, Imaging Subcommittee of International Harmonization Project in Lymphoma (2007) Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 25:571\u2013578","journal-title":"J Clin Oncol"},{"key":"1350_CR25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00259-017-3690-8","volume":"44","author":"SF Barrington","year":"2017","unstructured":"Barrington SF, Kluge R (2017) FDG-PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas. Eur J Nucl Med Mol Imaging 44:97\u2013110","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1350_CR26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"1000 Genomes Project Consortium, Auton A, Brooks LD et al (2015) A global reference for human genetic variation. Nature 526:68\u201374","journal-title":"Nature"},{"key":"1350_CR27","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.dnarep.2007.03.023","volume":"6","author":"JM Bugni","year":"2007","unstructured":"Bugni JM, Han J, Tsai MS, Hunter DJ, Samson LD (2007) Genetic association and functional studies of major polymorphic variants of MGMT. DNA Repair (Amst) 6:1116\u20131126","journal-title":"DNA Repair (Amst)"},{"key":"1350_CR28","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1080\/1120009X.2017.1312752","volume":"29","author":"MA Altinoz","year":"2017","unstructured":"Altinoz MA, Elmaci I, Bolukbasi FH, Ekmekci CG, Yenmis G, Sari R, Sav A (2017) MGMT gene variants, temozolomide myelotoxicity and glioma risk. A concise literature survey including an illustrative case. J Chemother 29:238\u2013244","journal-title":"J Chemother"},{"key":"1350_CR29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10571-016-0367-y","volume":"37","author":"K Liu","year":"2017","unstructured":"Liu K, Jiang Y (2017) Polymorphisms in DNA repair gene and susceptibility to glioma: a systematic review and meta-analysis based on 33 studies with 15 SNPs in 9 genes. Cell Mol Neurobiol 37:263\u2013274","journal-title":"Cell Mol Neurobiol"},{"key":"1350_CR30","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s10552-014-0423-1","volume":"25","author":"H Guo","year":"2014","unstructured":"Guo H, Bassig BA, Lan Q, Zhu Y, Zhang Y, Holford TR, Leaderer B, Boyle P, Qin Q, Zhu C, Li N, Rothman N, Zheng T (2014) Polymorphisms in DNA repair genes, hair dye use, and the risk of non-Hodgkin lymphoma. Cancer Causes Control 25:1261\u20131270","journal-title":"Cancer Causes Control"},{"key":"1350_CR31","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CEJ.0b013e328351c762","volume":"21","author":"J Jiao","year":"2012","unstructured":"Jiao J, Zheng T, Lan Q, Chen Y, Deng Q, Bi X, Kim C, Holford T, Leaderer B, Boyle P, Ba Y, Xia Z, Chanock SJ, Rothman N, Zhang Y (2012) Occupational solvent exposure, genetic variation of DNA repair genes, and the risk of non-Hodgkin\u2019s lymphoma. Eur J Cancer Prev 21:580\u2013584","journal-title":"Eur J Cancer Prev"},{"key":"1350_CR32","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1158\/1055-9965.EPI-06-0437","volume":"15","author":"L Wang","year":"2006","unstructured":"Wang L, Liu H, Zhang Z, Spitz MR, Wei Q (2006) Association of genetic variants of O6-methylguanine-DNA methyltransferase with risk of lung cancer in non-Hispanic Whites. Cancer Epidemiol Biomark Prev 15:2364\u20132369","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1350_CR33","first-page":"622","volume":"30","author":"F Yang","year":"2009","unstructured":"Yang F, Shi JY, Xu L et al (2009) Genetic susceptibility of single nucleotide polymorphism in MGMT to non-Hodgkin lymphoma. Zhonghua Xue Ye Xue Za Zhi 30:622\u2013625","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"1350_CR34","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/carcin\/bgl160","volume":"28","author":"J Hall","year":"2007","unstructured":"Hall J, Hashibe M, Boffetta P, Gaborieau V, Moullan N, Chabrier A, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates D, Janout V, Fabi\u00e1nov\u00e1 E, Holcatova I, Hung RJ, McKay J, Canzian F, Brennan P (2007) The association of sequence variants in DNA repair and cell cycle genes with cancers of the upper aerodigestive tract. Carcinogenesis 28:665\u2013671","journal-title":"Carcinogenesis"},{"key":"1350_CR35","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/neuonc\/nou003","volume":"16","author":"M Adel Fahmideh","year":"2014","unstructured":"Adel Fahmideh M, Schwartzbaum J, Frumento P, Feychting M (2014) Association between DNA repair gene polymorphisms and risk of glioma: a systematic review and meta-analysis. Neuro-Oncology 16:807\u2013814","journal-title":"Neuro-Oncology"},{"key":"1350_CR36","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s13277-013-1320-z","volume":"35","author":"Y Hu","year":"2014","unstructured":"Hu Y, Zhou M, Li K, Zhang K, Kong X, Zheng Y, Li J, Liu L (2014) Two DNA repair gene polymorphisms on the risk of gastrointestinal cancers: a meta-analysis. Tumour Biol 35:1715\u20131725","journal-title":"Tumour Biol"},{"key":"1350_CR37","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/carcin\/bgr211","volume":"32","author":"H Bye","year":"2011","unstructured":"Bye H, Prescott NJ, Matejcic M, Rose E, Lewis CM, Parker MI, Mathew CG (2011) Population-specific genetic associations with oesophageal squamous cell carcinoma in South Africa. Carcinogenesis 32:1855\u20131861","journal-title":"Carcinogenesis"},{"key":"1350_CR38","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1158\/1055-9965.EPI-07-2735","volume":"17","author":"M Zhang","year":"2008","unstructured":"Zhang M, Huang WY, Andreotti G, Gao YT, Rashid A, Chen J, Sakoda LC, Shen MC, Wang BS, Chanock S, Hsing AW (2008) Variants of DNA repair genes and the risk of biliary tract cancers and stones: a population-based study in China. Cancer Epidemiol Biomark Prev 17:2123\u20132127","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1350_CR39","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1215\/15228517-2008-080","volume":"11","author":"M Remington","year":"2009","unstructured":"Remington M, Chtchetinin J, Ancheta K, Nghiemphu PL, Cloughesy T, Lai A (2009) The L84F polymorphic variant of human O6-methylguanine-DNA methyltransferase alters stability in U87MG glioma cells but not temozolomide sensitivity. Neuro-Oncology 11:22\u201332","journal-title":"Neuro-Oncology"},{"key":"1350_CR40","first-page":"553","volume":"16","author":"SM Schwarzl","year":"2005","unstructured":"Schwarzl SM, Smith JC, Kaina B, Efferth T (2005) Molecular modeling of O6-methylguanine-DNA methyltransferase mutant proteins encoded by single nucleotide polymorphisms. Int J Mol Med 16:553\u2013557","journal-title":"Int J Mol Med"},{"key":"1350_CR41","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/CAD.0b013e3283407e9f","volume":"22","author":"RK Sylvester","year":"2011","unstructured":"Sylvester RK, Steen P, Tate JM, Mehta M, Petrich RJ, Berg A, Kolesar J (2011) Temozolomide-induced severe myelosuppression: analysis of clinically associated polymorphisms in two patients. Anti-Cancer Drugs 22:104\u2013110","journal-title":"Anti-Cancer Drugs"},{"key":"1350_CR42","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bcp.2007.09.022","volume":"75","author":"Q Fang","year":"2008","unstructured":"Fang Q, Loktionova NA, Moschel RC, Javanmard S, Pauly GT, Pegg AE (2008) Differential inactivation of polymorphic variants of human O6-alkylguanine-DNA alkyltransferase. Biochem Pharmacol 75:618\u2013626","journal-title":"Biochem Pharmacol"},{"key":"1350_CR43","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/sj.bjc.6601270","volume":"89","author":"S Ma","year":"2003","unstructured":"Ma S, Egyh\u00e1zi S, Ueno T, Lindholm C, Kreklau EL, Stierner U, Ringborg U, Hansson J (2003) O6-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma. Br J Cancer 89:1517\u20131523","journal-title":"Br J Cancer"},{"key":"1350_CR44","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.mrgentox.2013.09.007","volume":"758","author":"E Molina","year":"2013","unstructured":"Molina E, P\u00e9rez-Morales R, Rubio J, Petrosyan P, Cadena LH, Arlt VM, Phillips DH, Gonsebatt ME (2013) The GSTM1null (deletion) and MGMT84 rs12917 (Phe\/Phe) haplotype are associated with bulky DNA adduct levels in human leukocytes. Mutat Res 758:62\u201368","journal-title":"Mutat Res"},{"key":"1350_CR45","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/FPC.0b013e3281111eb1","volume":"17","author":"CE Hill","year":"2007","unstructured":"Hill CE, Wickliffe JK, Guerin AT, Kinslow CJ, Wolfe KJ, Ammenheuser MM, Abdel-Rahman SZ (2007) The L84F polymorphism in the O6-Methylguanine-DNA-Methyltransferase (MGMT) gene is associated with increased hypoxanthine phosphoribosyltransferase (HPRT) mutant frequency in lymphocytes of tobacco smokers. Pharmacogenet Genomics 17:743\u2013753","journal-title":"Pharmacogenet Genomics"},{"key":"1350_CR46","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/01.fpc.0000167332.38528.a5","volume":"15","author":"CE Hill","year":"2005","unstructured":"Hill CE, Wickliffe JK, Wolfe KJ, Kinslow CJ, Lopez MS, Abdel-Rahman SZ (2005) The L84F and the I143V polymorphisms in the O6-methylguanine-DNA-methyltransferase (MGMT) gene increase human sensitivity to the genotoxic effects of the tobacco-specific nitrosamine carcinogen NNK. Pharmacogenet Genomics 15:571\u2013578","journal-title":"Pharmacogenet Genomics"},{"key":"1350_CR47","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.1200\/JCO.2009.23.6497","volume":"27","author":"W Wick","year":"2009","unstructured":"Wick W, Hartmann C, Engel C, Stoffels M, Felsberg J, Stockhammer F, Sabel MC, Koeppen S, Ketter R, Meyermann R, Rapp M, Meisner C, Kortmann RD, Pietsch T, Wiestler OD, Ernemann U, Bamberg M, Reifenberger G, von Deimling A, Weller M (2009) NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol 27:5874\u20135880","journal-title":"J Clin Oncol"},{"key":"1350_CR48","doi-asserted-by":"crossref","first-page":"29727","DOI":"10.18632\/oncotarget.25696","volume":"9","author":"GC Bobustuc","year":"2018","unstructured":"Bobustuc GC, Kassam AB, Rovin RA et al (2018) MGMT inhibition in ER positive breast cancer leads to CDC2, TOP2A, AURKB, CDC20, KIF20A, Cyclin A2, Cyclin B2, Cyclin D1, ER\u03b1 and Survivin inhibition and enhances response to temozolomide. Oncotarget 9:29727\u201329742","journal-title":"Oncotarget"},{"key":"1350_CR49","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.bbrc.2005.09.177","volume":"337","author":"SK Niture","year":"2005","unstructured":"Niture SK, Doneanu CE, Velu CS, Bailey NI, Srivenugopal KS (2005) Proteomic analysis of human O6-methylguanine-DNA methyltransferase by affinity chromatography and tandem mass spectrometry. Biochem Biophys Res Commun 337:1176\u20131184","journal-title":"Biochem Biophys Res Commun"},{"key":"1350_CR50","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.neo.2018.01.010","volume":"20","author":"AGM Mostofa","year":"2018","unstructured":"Mostofa AGM, Punganuru SR, Madala HR, Srivenugopal KS (2018) S-phase specific downregulation of human O (6)-Methylguanine DNA Methyltransferase (MGMT) and its serendipitous interactions with PCNA and p21 (cip1) proteins in glioma cells. Neoplasia 20:305\u2013323","journal-title":"Neoplasia"},{"key":"1350_CR51","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.canep.2010.09.011","volume":"35","author":"YH Loh","year":"2011","unstructured":"Loh YH, Mitrou PN, Wood A, Luben RN, McTaggart A, Khaw KT, Rodwell SA (2011) SMAD7 and MGMT genotype variants and cancer incidence in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk Study. Cancer Epidemiol 35:369\u2013374","journal-title":"Cancer Epidemiol"},{"key":"1350_CR52","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA, Alliance, Australasian Leukaemia and Lymphoma Group, Eastern Cooperative Oncology Group, European Mantle Cell Lymphoma Consortium, Italian Lymphoma Foundation, European Organisation for Research, Treatment of Cancer\/Dutch Hemato-Oncology Group, Grupo Espa\u00f1ol de M\u00e9dula \u00d3sea, German High-Grade Lymphoma Study Group, German Hodgkin's Study Group, Japanese Lymphorra Study Group, Lymphoma Study Association, NCIC Clinical Trials Group, Nordic Lymphoma Study Group, Southwest Oncology Group, United Kingdom National Cancer Research Institute (2014) Recommendations for inital evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. JCO 32:3059\u20133068","journal-title":"JCO"},{"key":"1350_CR53","volume":"14","author":"L Kurch","year":"2018","unstructured":"Kurch L, Hasenclever D, Kluge R et al (2018) Only strongly enhanced residual FDG uptake in early response PET (Deauville 5 or qPET >\/= 2) is prognostic in pediatric Hodgkin lymphoma: results of the GPOH-HD2002 trial. Pediatr Blood Cancer 14:e27539","journal-title":"Pediatr Blood Cancer"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-019-01350-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-019-01350-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-019-01350-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T23:05:05Z","timestamp":1585782305000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-019-01350-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,3]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1350"],"URL":"https:\/\/doi.org\/10.1007\/s11307-019-01350-5","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"type":"print","value":"1536-1632"},{"type":"electronic","value":"1860-2002"}],"subject":[],"published":{"date-parts":[[2019,4,3]]},"assertion":[{"value":"3 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients and their guardians gave their written informed consent. The study was approved by the ethical committee of the Medical Faculty of the Martin Luther University Halle-Wittenberg.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}